Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China
· Delayed Price · Currency is CNY 48.39
-1.34 (-2.69%)
Apr 29, 2026, 3:04 PM CST
SHE:300832 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 39,074 | 55,668 | 61,443 | 39,416 | 34,652 | 54,455 | Upgrade
|
| Market Cap Growth | -17.08% | -9.40% | 55.88% | 13.75% | -36.36% | - | Upgrade
|
| Enterprise Value | 36,654 | 53,087 | 58,196 | 36,450 | 31,451 | 51,757 | Upgrade
|
| Last Close Price | 49.73 | 69.27 | 75.46 | 47.80 | 41.41 | 64.81 | Upgrade
|
| PE Ratio | 23.69 | 30.45 | 37.16 | 29.68 | 35.59 | 57.98 | Upgrade
|
| Forward PE | 20.92 | 25.23 | 31.02 | 27.83 | 28.70 | 47.78 | Upgrade
|
| PS Ratio | 8.59 | 12.27 | 15.64 | 12.94 | 13.61 | 24.81 | Upgrade
|
| PB Ratio | 4.47 | 6.49 | 8.14 | 6.16 | 6.18 | 11.34 | Upgrade
|
| P/TBV Ratio | 4.59 | 6.68 | 8.33 | 6.33 | 6.28 | 11.57 | Upgrade
|
| P/FCF Ratio | 34.71 | 60.69 | 56.06 | 70.49 | 80.54 | 75.44 | Upgrade
|
| P/OCF Ratio | 26.72 | 41.04 | 43.32 | 40.96 | 44.82 | 55.76 | Upgrade
|
| EV/Sales Ratio | 8.06 | 11.71 | 14.81 | 11.96 | 12.36 | 23.58 | Upgrade
|
| EV/EBITDA Ratio | 19.22 | 25.16 | 30.82 | 25.23 | 27.32 | 46.98 | Upgrade
|
| EV/EBIT Ratio | 21.51 | 27.47 | 33.48 | 27.35 | 29.74 | 50.61 | Upgrade
|
| EV/FCF Ratio | 32.56 | 57.88 | 53.09 | 65.19 | 73.10 | 71.70 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0.00 | 0 | 0 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.31 | -0.45 | -0.53 | -0.61 | -0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.19 | -1.25 | -1.80 | -2.36 | -2.97 | -3.06 | Upgrade
|
| Net Debt / FCF Ratio | -2.00 | -2.88 | -3.10 | -6.09 | -7.95 | -4.67 | Upgrade
|
| Asset Turnover | 0.49 | 0.51 | 0.52 | 0.46 | 0.45 | 0.50 | Upgrade
|
| Inventory Turnover | 1.40 | 1.20 | 1.21 | 1.22 | 1.33 | 1.44 | Upgrade
|
| Quick Ratio | 4.84 | 4.13 | 6.96 | 6.73 | 7.31 | 7.30 | Upgrade
|
| Current Ratio | 7.65 | 5.56 | 8.56 | 8.26 | 8.85 | 8.37 | Upgrade
|
| Return on Equity (ROE) | 19.56% | 22.68% | 23.72% | 22.11% | 18.70% | 23.65% | Upgrade
|
| Return on Assets (ROA) | 11.50% | 13.54% | 14.26% | 12.67% | 11.55% | 14.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 22.74% | 33.48% | 42.54% | 45.48% | 50.08% | 67.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.00% | 22.20% | 22.80% | 20.70% | 18.80% | 21.20% | Upgrade
|
| Earnings Yield | 4.22% | 3.28% | 2.69% | 3.37% | 2.81% | 1.73% | Upgrade
|
| FCF Yield | 2.88% | 1.65% | 1.78% | 1.42% | 1.24% | 1.33% | Upgrade
|
| Dividend Yield | 2.79% | 1.88% | 1.32% | 1.47% | 1.45% | 2.03% | Upgrade
|
| Payout Ratio | 61.92% | 42.98% | 33.15% | 35.53% | 42.46% | 65.91% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.01% | 0.07% | -0.04% | -4.76% | -6.61% | Upgrade
|
| Total Shareholder Return | 2.79% | 1.89% | 1.39% | 1.42% | -3.31% | -4.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.